REBECCA TREVINO: Open Payments
NPI 1285173047 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 49 payments from 13 companies in 2025. Trend: 2023 $1,104 · 2024 $648 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $599 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $196 |
| Novo Nordisk Inc | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Lundbeck LLC | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $41 |
| Corium, LLC | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
Products named: BOTOX, XIFAXAN, REXULTI, FARXIGA, QULIPTA, Ozempic, Veozah, Rybelsus.
Industry payments across FL — which companies pay providers there.
